Ligand Pharmaceuticals Incorporated
LGND
$104.97
$0.350.34%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 50.41% | 15.30% | 3.60% | 9.88% | -19.62% |
| Total Receivables | 7.98% | 35.35% | 38.18% | 6.33% | 12.20% |
| Inventory | -41.12% | -34.07% | -30.60% | 52.29% | 80.30% |
| Prepaid Expenses | 63.62% | -- | -- | -- | 4.42% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 535.94% | 1,057.56% | 840.90% | 102.10% | 17.20% |
| Total Current Assets | 39.65% | 21.81% | 12.85% | 12.41% | -9.93% |
|
|
|||||
| Total Current Assets | 39.65% | 21.81% | 12.85% | 12.41% | -9.93% |
| Net Property, Plant & Equipment | -1.02% | -3.03% | -4.06% | -10.86% | -8.84% |
| Long-term Investments | 1.82% | 1.43% | -0.40% | -0.40% | -2.18% |
| Goodwill | 1.82% | 1.43% | -0.40% | -0.40% | -2.18% |
| Total Other Intangibles | -11.00% | -14.48% | -15.77% | -15.37% | -15.04% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 179.73% | 1,238.64% | 875.80% | 1,296.53% | 605.51% |
| Total Assets | 19.63% | 24.13% | 14.29% | 12.67% | 3.22% |
|
|
|||||
| Total Accounts Payable | 115.62% | 89.66% | -81.29% | -69.14% | -54.27% |
| Total Accrued Expenses | 153.01% | 64.30% | 99.31% | -47.02% | -24.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 214.63% | 119.32% | 71.76% | -98.71% | -99.47% |
| Total Finance Division Other Current Liabilities | 31.26% | 22.48% | -59.12% | 2,056.48% | 38.22% |
| Total Other Current Liabilities | 31.26% | 22.48% | -59.12% | 2,056.48% | 38.22% |
| Total Current Liabilities | 121.14% | 57.51% | -36.83% | -81.99% | -83.02% |
|
|
|||||
| Total Current Liabilities | 121.14% | 57.51% | -36.83% | -81.99% | -83.02% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.56% | 7.46% | -41.63% | -53.29% | -44.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.23% | 3.61% | 25.35% | 54.27% | 13.77% |
| Total Liabilities | 29.00% | 12.20% | -2.15% | -34.85% | -47.75% |
|
|
|||||
| Common Stock & APIC | 69.79% | 68.12% | 39.90% | 41.33% | 34.62% |
| Retained Earnings | -0.80% | 9.33% | 8.51% | 19.55% | 11.57% |
| Treasury Stock & Other | -627.29% | 284.96% | 3.31% | 2.67% | 16.97% |
| Total Common Equity | 18.48% | 25.94% | 16.59% | 24.79% | 17.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.48% | 25.94% | 16.59% | 24.79% | 17.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.48% | 25.94% | 16.59% | 24.79% | 17.31% |
|
|
|||||